Does Spaying Before the First Heat Really Prevent Mammary Cancer in Dogs?
By Steve Mehler, DVM, DACVS
For decades, veterinarians have repeated a remarkably specific set of numbers when discussing when to spay a female dog:
Spay her before her first heat, and her risk of developing mammary tumors is only 0.5% of the risk in an intact female.
Wait until after one heat, and that relative risk increases to 8%.
Wait until after two heats, and it rises to 26%.
These statistics have appeared in veterinary textbooks, lectures, client education materials, and exam questions. They have also influenced millions of decisions about when dogs should be spayed.
There is just one problem: the scientific evidence supporting those remarkably precise numbers is much weaker than most of us were taught.
That does not mean early spaying has no protective effect. The real story is considerably more complicated.
Where did the 0.5%, 8%, and 26% numbers come from?
The biological argument behind early spaying makes sense.
Canine mammary tissue is hormonally responsive. Exposure to ovarian hormones—particularly estrogen and progesterone—can influence mammary tissue throughout a dog’s life.
Remove the ovaries early, reduce lifetime hormonal exposure, and it seems reasonable that mammary tumor risk might decrease.
Older observational studies appeared to support this relationship, eventually producing the now-famous figures associated with the number of estrous cycles a dog experienced before being spayed.
Over time, however, something important happened: a possible association gradually became presented as a remarkably precise biological rule.
That caught the attention of researchers.
Researchers put the evidence to the test
In 2012, Beauvais, Cardwell, and Brodbelt published a systematic review in the Journal of Small Animal Practice examining the effect of neutering on mammary tumor risk in dogs.
Rather than conducting another individual study, they asked a broader question:
How good is the entire body of evidence supporting this recommendation?
The researchers initially identified 11,149 search results. After applying their inclusion criteria, only 13 reports remained.
Then they evaluated the quality of those studies:
Nine of the 13 studies were judged to have a high risk of bias.
The remaining four were considered to have a moderate risk of bias.
Not one study was classified as having a low risk of bias.
What did the better studies find?
The four moderate-risk studies did not agree with one another:
One found an association between neutering and reduced mammary tumor risk.
Two found no evidence of an association.
One reported “some protective effect” but did not provide numerical estimates.
The authors therefore reached a conclusion that was surprisingly different from the certainty with which this topic is often discussed in veterinary medicine.
They judged the evidence that neutering reduces the risk of mammary neoplasia to be weak. They also concluded that evidence supporting an effect of age at neutering was weak and that the available evidence was not a sound basis for firm recommendations.
That is a remarkable conclusion considering how firmly many of us learned the 0.5%, 8%, and 26% figures.
This does not mean spaying fails to reduce mammary cancer
This distinction is critical.
Finding weak evidence for an effect is not the same as finding evidence of no effect. Those are very different scientific statements.
The biological mechanism remains plausible, and several observational studies have reported lower mammary tumor rates among dogs spayed earlier in life. The problem is determining exactly how large that protective effect is.
Studying this question properly is surprisingly difficult.
Why is this question so hard to answer?
Imagine designing the ideal experiment. You would take thousands of genetically and environmentally similar puppies and randomly assign them to groups:
Spayed before the first heat
Spayed after one heat
Spayed after two heats
Spayed several years later
Remaining intact throughout life
You would then follow every dog for perhaps 10 to 15 years and determine how many developed mammary tumors.
That experiment would provide extraordinarily valuable information. It would also create enormous practical and ethical difficulties.
Consequently, much of the evidence comes from observational studies, which are vulnerable to confounding. Dogs spayed early may differ from dogs spayed later in ways extending far beyond ovarian hormone exposure.
Potential confounders include:
Breed and genetics
Body condition
Age and environment
Geographic location
Access to veterinary care
Owner behavior
The reason a dog was—or was not—spayed
Mammary tumors also frequently develop later in life, meaning studies need long follow-up periods to capture the true outcome.
These factors make establishing causation—and especially calculating precise percentages—very difficult.
More than a decade later, researchers looked again
A 2025 systematic review evaluated newer studies and specifically examined whether prepubertal spaying protects dogs against mammary tumors.
Once again, 13 studies met the review’s criteria. And once again, the evidence was not nearly as straightforward as conventional wisdom might suggest.
Six of the 13 studies found no evidence that early spaying protected against mammary tumors. Other studies did find evidence suggesting protection.
For example, one study involving 599 dogs reported significantly lower mammary tumor risk among dogs spayed before two years of age compared with dogs spayed later or remaining intact.
So there is legitimate evidence pointing toward a protective relationship. The issue is that the literature remains inconsistent.
So, are the famous numbers wrong?
Not necessarily.
A better description is that they are much less certain than their precision makes them sound.
There is an enormous difference between saying:
“Spaying before the first heat reduces mammary tumor risk to exactly 0.5% of the risk in an intact dog.”
and saying:
“Earlier spaying may reduce mammary tumor risk, but we do not know the magnitude of that protection nearly as precisely as the traditional numbers suggest.”
The second statement better reflects the limitations of the current evidence.
This is an important concept in evidence-based medicine: a number can be repeated so frequently that eventually we stop asking where it came from. Repetition does not improve the quality of the original evidence.
This is not an argument against spaying
Mammary cancer represents only one consideration when deciding whether—and when—to spay a dog.
Removing ovarian function also prevents pregnancy and essentially eliminates the future risk of pyometra when the relevant reproductive tissue is removed.
On the other side of the equation, research increasingly suggests that the timing of gonadectomy may interact with other health outcomes, potentially including orthopedic disease and urinary incontinence. Some of these relationships appear to differ considerably among breeds and individual dogs.
The modern conversation surrounding spay timing is therefore moving away from a universal rule that every dog should be spayed at exactly the same age.
Instead, veterinarians can consider the entire patient:
Breed and expected adult size
Lifestyle and reproductive risk
Orthopedic considerations
The owner’s ability to manage an intact female
The risks associated with remaining intact
Mammary tumor risk belongs in that discussion. It simply should not be represented with more certainty than the evidence allows.
The bigger lesson for veterinary medicine
This story is not really just about spaying. It is about how medical dogma develops.
A study produces an interesting result. The result enters textbooks. The textbook enters lectures. The lecture becomes a recommendation. The recommendation gets repeated for decades.
Eventually, a nuanced scientific observation can become a seemingly unquestionable fact.
Systematic reviews force us to go backward and ask an uncomfortable but essential question:
How strong was the evidence in the first place?
Sometimes the answer reinforces what we have been teaching. Sometimes it does not.
And sometimes—as appears to be the case here—the answer is simply that we do not know as precisely as we thought we did.
Bottom line
Earlier spaying may reduce the risk of mammary tumors in dogs, and both biological plausibility and observational evidence support a protective effect.
But the magnitude of that protection remains uncertain.
The traditional 0.5%, 8%, and 26% figures should therefore be interpreted cautiously rather than presented as precise, unquestionable risks.
That does not make the decision to spay wrong. It makes the conversation better.
Good evidence-based medicine is not about abandoning recommendations every time uncertainty appears. It is about being honest about what we know, what we do not know, and how certain we should be.
References
Beauvais W, Cardwell JM, Brodbelt DC. The effect of neutering on the risk of mammary tumours in dogs—a systematic review. Journal of Small Animal Practice. 2012;53:314–322.
Wisner ER, Nolan AM, Church DB. Systematic review examining the relationship between prepubertal spaying and mammary tumour risk in dogs. Frontiers in Veterinary Science. 2025.
Comments